These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23104579)

  • 1. Evaluation of crystallization behavior on the surface of nifedipine solid dispersion powder using inverse gas chromatography.
    Miyanishi H; Nemoto T; Mizuno M; Mimura H; Kitamura S; Iwao Y; Noguchi S; Itai S
    Pharm Res; 2013 Feb; 30(2):502-11. PubMed ID: 23104579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
    Aso Y; Yoshioka S; Kojima S
    J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the structural relaxation at the surface of amorphous solid dispersion using inverse gas chromatography.
    Hasegawa S; Ke P; Buckton G
    J Pharm Sci; 2009 Jun; 98(6):2133-9. PubMed ID: 18837010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden rise of crystal growth rate of nifedipine near T(g) without and with polyvinylpyrrolidone.
    Ishida H; Wu T; Yu L
    J Pharm Sci; 2007 May; 96(5):1131-8. PubMed ID: 17455342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-state characterization of nifedipine solid dispersions.
    Vippagunta SR; Maul KA; Tallavajhala S; Grant DJ
    Int J Pharm; 2002 Apr; 236(1-2):111-23. PubMed ID: 11891075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP.
    Caron V; Bhugra C; Pikal MJ
    J Pharm Sci; 2010 Sep; 99(9):3887-900. PubMed ID: 20575050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.
    Marsac PJ; Konno H; Rumondor AC; Taylor LS
    Pharm Res; 2008 Mar; 25(3):647-56. PubMed ID: 17846870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation.
    Aso Y; Yoshioka S; Miyazaki T; Kawanishi T; Tanaka K; Kitamura S; Takakura A; Hayashi T; Muranushi N
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1227-31. PubMed ID: 17666850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the physical stability of amorphous felodipine and nifedipine systems.
    Marsac PJ; Konno H; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2306-16. PubMed ID: 16927182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of polymer concentration on the molecular mobility and physical stability of nifedipine solid dispersions.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2015 May; 12(5):1477-84. PubMed ID: 25894099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of Crystallinity of Nifedipine-Polyvinylpyrrolidone Solid Dispersion by Usage of Terahertz Time-Domain Spectroscopy and of X-Ray Powder Diffractometer.
    Takeuchi I; Shimakura K; Kuroda H; Nakajima T; Goto S; Makino K
    J Pharm Sci; 2015 Dec; 104(12):4307-4313. PubMed ID: 26461839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin of Nanodroplet Formation Upon Dissolution of an Amorphous Solid Dispersion: A Mechanistic Isotope Scrambling Study.
    Indulkar AS; Waters JE; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    J Pharm Sci; 2017 Aug; 106(8):1998-2008. PubMed ID: 28431965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
    Huang J; Wigent RJ; Schwartz JB
    J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
    Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
    Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times.
    Aso Y; Yoshioka S; Kojima S
    J Pharm Sci; 2000 Mar; 89(3):408-16. PubMed ID: 10707020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine.
    Cai T; Zhu L; Yu L
    Pharm Res; 2011 Oct; 28(10):2458-66. PubMed ID: 21638137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer blends used to prepare nifedipine loaded hollow microspheres for a floating-type oral drug delivery system: in vitro evaluation.
    Zhao L; Wei YM; Yu Y; Zheng WW
    Arch Pharm Res; 2010 Mar; 33(3):443-50. PubMed ID: 20361310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers.
    Suzuki H; Sunada H
    Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):482-7. PubMed ID: 9549890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating miscibility and molecular mobility of nifedipine-PVP amorphous solid dispersions using solid-state NMR spectroscopy.
    Yuan X; Sperger D; Munson EJ
    Mol Pharm; 2014 Jan; 11(1):329-37. PubMed ID: 24256090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.